COPD Clinical Trials
Find clinical trials for COPD. Search for COPD clinical trials in different cities and states across the United States.
Mitochondrial Derived Reactive Oxygen Species on Cardiovascular Health in Chronic Obstructive Pulmonary Disease (COPD)
Sponsor:
Virginia Commonwealth University
Location:
Code:
NCT05605548
Conditions
Chronic Obstructive Pulmonary Disease
Eligibility Criteria
Sex: All
Age: 40+
Healthy Volunteers: Not accepted
Interventions
MitoQ
Placebo
The Effect of Respiratory Training on Exercise Tolerance in COPD
Sponsor:
Laval University
Location:
Code:
NCT04201522
Conditions
Pulmonary Disease, Chronic Obstructive
Eligibility Criteria
Sex: All
Age: 40+
Healthy Volunteers: Not accepted
Interventions
Normocapnic hyperpnoea intervention
Sham intervention
Cognitive and Physical Training in Patients With Chronic Obstructive Pulmonary Disease Patients
Sponsor:
University Health Network, Toronto
Location:
Code:
NCT05140226
Conditions
Pulmonary Disease, Chronic Obstructive
Eligibility Criteria
Sex: All
Age: 50+
Healthy Volunteers: Not accepted
Interventions
Physical Training
Cognitive-Physical Training
An Evaluation of the AeriSeal System for CONVERTing Collateral Ventilation Status in Patients with Severe Emphysema
Sponsor:
Pulmonx Corporation
Location:
Code:
NCT06035120
Conditions
Emphysema, Pulmonary
Emphysema or COPD
Eligibility Criteria
Sex: All
Age: 22 - 70+
Healthy Volunteers: Not accepted
Interventions
AeriSeal System
Enhanced Pulmonary Rehabilitation With Digital Remote Home Monitoring
Sponsor:
University of Alberta
Location:
Code:
NCT06077994
Conditions
Chronic Obstructive Pulmonary Disease
Eligibility Criteria
Sex: All
Age: 30 - 70+
Healthy Volunteers: Not accepted
Interventions
digital Remote Patient Monitoring+BEPR+ (dRPM+)
Enhanced Breathe Easy Pulmonary Rehabilitation Program (BEPR+)
A Study Evaluating the Efficacy of Budesonide, Glycopyrronium and Formoterol Fumarate Metered Dosed Inhaler on Cardiopulmonary Outcomes in Chronic Obstructive Pulmonary Disease
Sponsor:
AstraZeneca
Location:
Code:
NCT06283966
Conditions
COPD (Chronic Obstructive Pulmonary Disease)
Eligibility Criteria
Sex: All
Age: 40 - 70+
Healthy Volunteers: Not accepted
Interventions
BGF MDI 320/14.4/9.6 μg
GFF MDI 14.4/9.6 μg
Glittre ADL-test: Responsiveness to Acute Bronchodilation in Chronic Obstructive Pulmonary Disease (COPD)
Sponsor:
Laval University
Location:
Code:
NCT03071731
Conditions
Chronic Obstructive Pulmonary Disease
Eligibility Criteria
Sex: All
Age: 40+
Healthy Volunteers: Not accepted
Interventions
Bronchodilators
Placebos
What are COPD clinical trials?
COPD clinical trials are research studies aimed at evaluating new treatments, interventions, or management strategies for Chronic Obstructive Pulmonary Disease (COPD). These trials aim to discover more effective ways to alleviate symptoms, slow disease progression, and improve the quality of life for individuals living with COPD.
The importance of clinical trials in COPD research
Clinical trials play a vital role in COPD research, offering the most reliable method to test the safety and effectiveness of new therapies. Through these studies, researchers can identify better ways to manage COPD, uncover insights into its pathophysiology, and potentially find a cure.
Types of COPD clinical trials
Types of COPD clinical trials include a wide range of studies focused on improving treatment and management of the disease. These trials test new medications and inhaler technologies, assess physical therapy and rehabilitation programs, explore oxygen and ventilatory support options, evaluate the effectiveness of surgical and interventional procedures, and examine lifestyle and behavioral changes. Each type of trial aims to find better ways to manage COPD symptoms, enhance patient quality of life, and slow disease progression.
Trials focused on medication and inhaler therapies
These trials evaluate new drugs or combinations of medications administered through inhalers, aiming to reduce the frequency of COPD flare-ups, improve lung function, and alleviate symptoms. They often explore the efficacy of bronchodilators, corticosteroids, and other pharmacological treatments in managing COPD.
Physical therapy and rehabilitation trials
Rehabilitation trials investigate the benefits of physical therapy programs, including exercises designed to enhance respiratory function, increase stamina, and improve overall physical fitness in COPD patients. These studies assess how rehabilitation impacts the quality of life, exercise tolerance, and disease progression.
Oxygen and ventilatory support trials
These studies explore the effectiveness of supplemental oxygen therapy and mechanical ventilatory support in individuals with COPD, particularly those with severe disease. Trials may investigate the optimal timing, delivery methods, and outcomes of using oxygen therapy and non-invasive ventilation to manage chronic respiratory failure.
Surgical and interventional procedures trials
Trials exploring surgical and interventional procedures assess the outcomes of surgical and minimally invasive procedures, such as lung volume reduction surgery (LVRS), bullectomy, or endobronchial valve placement. These studies aim to determine how well these interventions improve breathing, reduce symptoms, and enhance the quality of life for patients with advanced COPD.
Lifestyle and behavioral modification trials
Lifestyle and behavioral modification trials examine the impact of dietary changes, smoking cessation, stress management and other lifestyle interventions on COPD management. They investigate how behavioral interventions can affect disease progression, symptom control, and overall well-being.
Who can participate in COPD clinical trials?
Individuals diagnosed with COPD at various stages of the disease may be eligible to participate in clinical trials. Eligibility criteria vary depending on the study's objectives and may include factors like age, smoking history, severity of COPD, and current treatments. Some trials may specifically seek participants with certain COPD characteristics or those who have not responded to standard treatments.
What to expect in a COPD trial
Participants in a COPD clinical trial can expect a comprehensive process that begins with eligibility screening and informed consent. During the trial, participants may receive new treatments or interventions and undergo regular monitoring, including medical assessments, lung function tests, and questionnaires about their symptoms and quality of life. Trials are conducted under strict safety protocols, with participants' health and well-being as the top priority.
How to enroll in a COPD clinical trial
Enrolling in a COPD clinical trial through our platform is a straightforward and user-friendly process. Here's how to get started:
- Identify Your Trial: Use our intuitive search bar or filter options to locate clinical trials specific to requirements. This first step simplifies the process of finding relevant research studies tailored to your needs.
- Select Your Preferred Location: To find trials conveniently located near you, simply input your preferred location into the dedicated filter bar on the left-hand side of the page.
- Explore Study Details: For in-depth information about each study, simply click the “Learn More” button. This will provide you with comprehensive details about the trial, including objectives, procedures, and eligibility criteria.
- Complete the Health Profile: After clicking on the “Get started” button you will be taken to our efficient 5-step application process to provide important health information. This helps us match you with the clinical trial that best fits your needs.
- Submit the Application: After completing the application, send it in. A clinical trial coordinator will review it and contact you regarding the possibility of participation.